Top Tweets for #Chrysalis2
Data from 4 studies that we touched on during our Lung Cancer Conference Highlights from #ASCO26 w/ @ipreeshagul
✅ #LIBRETTO432
✅ #CROWN
✅ #CHRYSALIS2
✅ #HARMONi6
#lcsm #OncTwitter @OncUpdates

Lung Cancer Conference Highlights from #ASCO26 w/ @ipreeshagul
✅ #LIBRETTO432
✅ #CROWN (& LORIN)
✅ #CHRYSALIS2
✅ #HARMONi6
✅ A quick mention about DeLLphi304
Full 🗣️
⭐️ OncBrothers & @OncUpdates website
⭐️“Oncology Brothers” podcast
#OncTwitter #lcsm #MedTwitter
Highly Recommended: Lung Cancer Conference Highlights from #ASCO26 w/ @ipreeshagul
✅ #LIBRETTO432
✅ #CROWN (& LORIN)
✅ #CHRYSALIS2
✅ #HARMONi6 https://t.co/6FMgXan0Vl
Lung Cancer Conference Highlights from #ASCO26 w/ @ipreeshagul
✅ #LIBRETTO432
✅ #CROWN (& LORIN)
✅ #CHRYSALIS2
✅ #HARMONi6
✅ A quick mention about DeLLphi304
Full 🗣️
⭐️ OncBrothers & @OncUpdates website
⭐️“Oncology Brothers” podcast
#OncTwitter #lcsm #MedTwitter
Lung Cancer Conference Highlights from #ASCO26 w/ @ipreeshagul
✅ #LIBRETTO432
✅ #CROWN (& LORIN)
✅ #CHRYSALIS2
✅ #HARMONi6
✅ A quick mention about DeLLphi304
Full 🗣️
⭐️ OncBrothers & @OncUpdates website
⭐️“Oncology Brothers” podcast
#OncTwitter #lcsm #MedTwitter
🎥 Our first batch of interviews on Day 2 of #ASCO26 are officially in the books!
A big thank you to @JoelNealMD, (@StanfordCancer), Jonathan Goldman, MD, and @JordynSilvs (@UCLAHealthJCCC), stopping by to discuss:
🫁 Updated data from #CHRYSALIS2 in atypical EGFR-mutated advanced NSCLC
🫁 Primary data from the phase 3 #LIBRETTO432 trial in RET+ NSCLC
🩺 New efficacy, safety, and biomarker findings with abemaciclib plus hormonal therapy in recurrent #ovarian and #endometrial cancers.
Stay tuned for more from these conversations and follow along at https://t.co/0lpCb0twb0 for continuing @ASCO coverage, breaking data, and expert insights. 🔬 #ovca #gynsm #lcsm

Great to see these results presented here at #ASCO2026. Important results for patients with newly diagnosed atypical #EGFR mutations from the #Chrysalis2. #MyCompany

NSCLC w/ #EGFR 🎯 is rapidly changing. @IASLC we saw #FLAURA2, #CHRYSALIS2, & #HerthenaLung01.
Just before @myESMO, in this #CME 🗣️ w/ @NarjustFlorezMD @CharuAggarwalMD @JackWestMD we focus on Rx in 2L & beyond in this disease.
https://t.co/uHlbwFcRFm
#lcsm #OncTwitter

#WCLC23 Lung Ca highlights w/@StephenVLiu for community oncologists:
#FLAURA2
#MARS2
#CHRYSALIS2
#EVOKE2
Full discussion:
- https://t.co/h4T6b2GACr
- https://t.co/dsgHeeyY1k
- Also on “Oncology Brothers” podcast
#OncTwitter #LCSM #MedTwitter #MedEd @TargetedOnc @IASLC
5. 2L for pts with mEGFR after TKI:
a. #CHRYSALIS2: #Amivantamab + #Lazertinib + Chemo, ORR: 50%. High cytopenias. Amivant. Also very active as a single agent in 1st and 2L for #MetExon14
b. #HERTHENALung01: #Her3DXd ADC with activity post TKI. ORR: 30%, mOS ~12 months

#WCLC23 Highlights #CommunityOncology 🔎:
1. #IMPower133 update ES-SCLC @StephenVLiu
2. #DESTINYLung02 Her2 NSCLC
3. #MARS2: ✂️mesothelioma @ekslim
4. #FLAURA2: 1L mEGFR
5. 2L mEGFR: #CHRYSALIS2 #HERTHENALung01
6. TNM 9thEd
#lcsm @IASLC #OncTwitter #MedTwitter #MedEd

Update on Amivantamab ➕ Lazertinib
‼️ Is it time to routinely test for MET IHC in our patients w/ EGFR mutant mNSCLC who progress on osimertinib?
👉🏽 If yes, making sure we obtain sufficient tissue at progression will be ESSENTIAL! #ASCO23 #CHRYSALIS2 #lcsm @LungCancerRx

#ASCO23 Abs9042 #LCSM
#CHRYSALIS2: Amivantamab+lazertinib in post-osimertinib, chemo-naïve EGFR-mutated advanced NSCLC.
➡️101 evaluable patients, IHC-based MET expression found predictive for response🧪.
➡️ MET+ ORR 61% (95% CI, 41–78) vs MET- ORR 12% (95% CI, 5–25) 💯.
➡�� No predictive biomarkers identified via ctDNA NGS🔬.
🏁 Amivantamab+lazertinib could be a chemo-free option for EGFR-mutated advanced NSCLC post-osimertinib, especially for MET+ pts by IHC. https://t.co/QSyLnXXQpI
@Oncoalert @OncBrothers @LungCancerRx #ADLCSM @BenjaminBesseMD

Last Seen Hashtags on Sotwe
lovecam
Seen from Algeria
doro
Seen from France
国漫精品
ai mommy son
nolimit(******)**************************************+filter:native_video
Seen from Belgium
cuckold
Seen from Germany
魔法少女にあこがれて
Seen from Japan
canakkalepasif
Seen from Turkey
ManojChhabra
Seen from United States
خلفي
Seen from Saudi Arabia
Most Popular Users

Elon Musk 
@elonmusk
240.5M followers

Barack Obama 
@barackobama
118.7M followers

Cristiano Ronaldo 
@cristiano
114.4M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
84M followers

Lady Gaga 
@ladygaga
75.5M followers

Virat Kohli 
@imvkohli
73.4M followers

Kim Kardashian 
@kimkardashian
70.8M followers

YouTube 
@youtube
68.7M followers

Neymar Jr 
@neymarjr
66.3M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63M followers

The Ellen Show
@theellenshow
62.1M followers

CNN 
@cnn
61.7M followers

X 
@x
60.6M followers









